Çocukluk Çağında Akut Myeloid Lösemi

Abstract

Acute leukemia is basically divided into acute lymphoblastic leukemia and acute myeloid leukemia (AML). About 15-20% of childhood leukemia is caused by AML. AML is classified according to morphological, cytochemical and immunophenotypic characteristics. AML patients may present with various clinical signs and symptoms due to leukemic cell infiltration. Age, gender, race, structural features of the patient and cytogenetic abnormalities are important factors affecting prognosis in AML. The goal in the treatment of AML is to provide complete remission with the least toxicity given to the patient and to maintain this remission. In this study, etiology, classification, clinical features, prognosis and treatment strategies of childhood AML were investigated.